Stockscreener 앱 받기
7.92
3.26%
0.25
전일 마감가:
$7.67
열려 있는:
$7.59
하루 거래량:
212.91K
Relative Volume:
1.01
시가총액:
$207.58M
수익:
$47.26M
순이익/손실:
$-58.48M
주가수익비율:
-2.928
EPS:
-2.7049
순현금흐름:
$-40.45M
1주 성능:
+10.31%
1개월 성능:
-12.49%
6개월 성능:
+20.36%
1년 성능:
-41.20%
1일 변동 폭
$7.505
$7.96
1주일 범위
$6.98
$7.96
52주 변동 폭
$4.2993
$18.55
Cvrx Inc Stock (CVRX) Company Profile
명칭
Cvrx Inc
전화
(763) 416-2850
주소
9201 WEST BROADWAY AVENUE, MINNEAPOLIS
CVRX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CVRX
Cvrx Inc
|
7.92 | 201.03M | 47.26M | -58.48M | -40.45M | -2.7049 |
|
ABT
Abbott Laboratories
|
127.78 | 219.88B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
97.79 | 141.54B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
366.39 | 133.39B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.31 | 124.82B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
85.85 | 48.84B | 5.88B | 1.34B | 799.60M | 2.3489 |
Cvrx Inc Stock (CVRX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-09 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2025-01-14 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2024-09-10 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-07-11 | 재확인 | Lake Street | Buy |
| 2024-05-01 | 재개 | Craig Hallum | Buy |
| 2024-05-01 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-05-01 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2023-01-31 | 개시 | Lake Street | Buy |
| 2022-07-18 | 개시 | Craig Hallum | Buy |
| 2021-07-26 | 개시 | Canaccord Genuity | Buy |
| 2021-07-26 | 개시 | Piper Sandler | Overweight |
| 2021-07-26 | 개시 | William Blair | Outperform |
모두보기
Cvrx Inc 주식(CVRX)의 최신 뉴스
CVRx’s Barostim therapy receives Category I CPT codes By Investing.com - Investing.com India
Cvrx announces implementation of new category I CPT codes for Barostim therapy - marketscreener.com
CVRx announces implementation of new category I CPT codes for Barostim therapy - TipRanks
CVRx, Inc. Announces Transition to Category I CPT Codes for Barostim Therapy Effective January 1, 2026 - Quiver Quantitative
CVRx Announces Implementation of New Category I CPT Codes for Barostim Therapy - The Manila Times
CVRx signals gratitude towards healthcare community amid heart failure treatment advancements - Traders Union
Institution Moves: Can CVRX stock resist market sell offs2025 Momentum Check & Long-Term Growth Portfolio Plans - moha.gov.vn
Technical Reactions to CVRX Trends in Macro Strategies - Stock Traders Daily
CVRx, Inc.'s (NASDAQ:CVRX) Popularity With Investors Under Threat As Stock Sinks 26% - simplywall.st
CVRx upgraded by William Blair to outperform - MSN
CVRx to Present at the 44th Annual J.P. Morgan Healthcare Conference - Sahm
CVRx supports St. Cloud Hospital with Barostim implants - Traders Union
CVRx, Inc. (NASDAQ:CVRX) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Why CVRx Inc. stock is a must watch in 2025July 2025 Setups & Community Verified Swing Trade Signals - Улправда
Will CVRX stock reach Wall Street targetsJuly 2025 Recap & Fast Moving Market Watchlists - Bölüm Sonu Canavarı
Why CVRx Inc. stock is favored by pension funds2025 Major Catalysts & Risk Managed Trade Strategies - Улправда
Earnings Report: Will CVRX stock deliver long term returnsJuly 2025 Patterns & Long-Term Capital Growth Strategies - Bollywood Helpline
CVRx marks milestone with 25 Barostim implants at Los Robles - Traders Union
Discipline and Rules-Based Execution in CVRX Response - Stock Traders Daily
Why CVRx Inc. stock remains a top recommendation - Улправда
Is CVRx Inc. stock positioned for long term growthJuly 2025 Market Mood & Daily Profit Maximizing Trade Tips - DonanımHaber
What analyst consensus says on CVRX stock2025 Growth vs Value & Accurate Technical Buy Alerts - Улправда
How resilient is CVRX stock in market downturnsJuly 2025 Big Picture & Precise Buy Zone Identification - DonanımHaber
Analysts Offer Insights on Healthcare Companies: Pulmonx (LUNG), Novan (NOVN) and CVRx (CVRX) - The Globe and Mail
Is CVRX stock a buy on dips2025 Price Momentum & AI Powered Trade Plan Recommendations - Улправда
Earnings Risk: Why CVRx Inc. stock is a must watch in 2025July 2025 Rallies & Stock Portfolio Risk Management - Улправда
How CVRx Inc. stock reacts to Fed rate cutsWeekly Investment Recap & Fast Moving Stock Trade Plans - Улправда
Will CVRX stock outperform tech sector in 2025Earnings Growth Summary & Real-Time Volume Analysis Alerts - Улправда
CVRx hosts webinar on Barostim coding updates ahead of 2026 - Traders Union
CVRx Earnings Notes - Trefis
CVRx prepares for Jan 2026 Barostim billing update - Traders Union
Behavioral Patterns of CVRX and Institutional Flows - news.stocktradersdaily.com
Would You Still Hold CVRx Stock If It Fell Another 30%? - Trefis
Is CVRx Inc. stock supported by strong fundamentals2025 Market Sentiment & Risk Managed Trade Strategies - Newser
Why CVRX stock could rally in 20252025 Institutional Moves & Growth Focused Stock Pick Reports - Newser
Johnson & Johnson's Strategic Adjustment in CVRx Inc Holdings - GuruFocus
Johnson & Johnson sells CVRx (CVRX) shares worth $63,560 - Investing.com India
Johnson & Johnson Makes a Bold Move with CVRx Stock Sale! - TipRanks
Johnson & Johnson sells CVRx (CVRX) shares worth $63,560 By Investing.com - Investing.com Australia
Jobs Data: Will CVRX stock deliver long term returnsMarket Sentiment Review & Capital Efficient Trading Techniques - BỘ NỘI VỤ
CVRX 8-K & SEC Filings - Yahoo Finance
Will CVRX stock deliver long term returnsJuly 2025 Volume & Low Volatility Stock Recommendations - BỘ NỘI VỤ
CVRx stock slides on preliminary revenue miss - MSN
CVRx, Inc. (NASDAQ:CVRX) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
CVRx (CVRX) Gets a Buy from Canaccord Genuity - The Globe and Mail
Johnson & Johnson Makes a Strategic Move with CVRx Stock Sale! - TipRanks
CVRx stock holds Buy rating at Canaccord as CMS finalizes 2026 payment - Investing.com Nigeria
Johnson & Johnson innovation sells $27,132 in CVRx shares By Investing.com - Investing.com South Africa
Johnson & Johnson innovation sells $27,132 in CVRx shares - Investing.com India
Cvrx Inc (CVRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.82%
자본화:
|
볼륨(24시간):